Skip to content

Automated Postoperative Sedation After Cardiac Surgery

Postoperative Sedation After Cardiac Surgery : Comparison Between Manual Administration and Automated Sedation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03517735
Acronym
SEPOCA
Enrollment
7
Registered
2018-05-07
Start date
2018-12-17
Completion date
2019-03-30
Last updated
2021-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Sedation, Surgery, Cardiac

Brief summary

This study compares automated administration of propofol and remifentanil guided by the Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.

Detailed description

Automated sedation has the potential to improve patient care after cardiac surgery by adjusting drug doses to the minimum required for efficacy. Indeed, automated and continuous titration may avoid overdosing, improve hemodynamic stability and also decrease the mean time to tracheal extubation. Medsteer SAS developed a controller, EasyTiva device, allowing the closed-loop coadministration of propofol and remifentanil, guided by a Bispectral Index (BIS) monitor. Automated sedation is so facilitated by the BIS which permits continuous monitoring of electrocortical activity. This randomized monocentric trial compares the automated administration with manual intravenous administration of propofol-remifentanil for maintaining adequate depth of hypnosis (BIS 55-75) during sedation after cardiac surgery.

Interventions

DEVICEEasyTiva (algorithm is the property of Medsteer SAS)

Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.

DRUGPropofol

The dosage is modified automatically by the device or according to the new medical prescription.

DRUGRemifentanil

The dosage is modified automatically by the device or according to the new medical prescription.

Sponsors

CMC Ambroise Paré
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Cardiac surgical procedure requiring postoperative sedation * Low operative risk : EuroSCORE 2 ≤ 5% * Consent for participation * Affiliation to the social security system

Exclusion criteria

* Pregnant or breastfeeding women * Neurological or muscular disorder * Pacemaker * Hypersensitivity to propofol or remifentanil * Communication difficulties or neuropsychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Adequate sedation6 hoursPercentage of time with BIS between 55 and 75 (BIS(55-75))

Secondary

MeasureTime frameDescription
Period of too light sedation6 hoursPercentage of time with BIS values greater than 75
Incidence of Burst Suppression (bsr) during sedation6 hoursPresence of Burst Suppression defined by a rate \> 10% for at least one minute
Level of sedation6 hoursRichmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert & calm)
Level of pain during sedation6 hoursBehavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed : * Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing) * Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted) * Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)
Medical interventions6 hoursNumber and causes of transient or permanent interruptions in automated administration
Hemodynamic status during the sedation period6 hoursEvolution of hemodynamic parameters (composite : arterial blood pressure in mmHg and heart rate in bpm)
Period of too deep sedation6 hoursPercentage of time with BIS values less than 55
Delay before awakening6 hoursDelay between the cessation of infusion of propofol and remifentanil and extubation.
Dose of hypnotic drug6 hoursTotal amount of propofol during sedation period
Dose of analgesic drug6 hoursTotal amount of remifentanil during sedation period
Level of consciousness after extubation9 hoursRichmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert & calm)
Level of pain after extubation9 hoursBehavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed : * Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing) * Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted) * Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)
Awareness during the sedation period48 hoursAwareness standardized questionnaire
Sedation time6 hoursDuration of sedation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026